EthOss TCP - Dental bone matrix implant, synthetic
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
28-05-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
W9 Pty Ltd
Class:
Class III
Manufactured by:
Medbone-Medical Devices Lda Centro Empresarial Lusoworld II R Pe de Mouro 26 , Sintra, 2710-335 Portugal
Therapeutic area:
47971 - Dental bone matrix implant, synthetic
Therapeutic indications:
EthOss TCP is a synthetic, resorbable, osteoconductive bone graft material composed of 65% beta tricalcium phosphate (?-TCP) and 35% medical grade calcium sulfate (CaSO4). It is provided as a dry powder packaged within a syringe to be mixed with sterile saline to form a paste and applied through the syringe. EthOss TCP is intended to fill, augment, or reconstruct periodontal or bony defects of the oral and maxillofacial region.
Authorization status:
A
Authorization date:
2018-02-22
